Skip to main content

Table 2 Procedural details

From: The impact of the use of bioresorbable vascular scaffolds and drug-coated balloons in coronary bifurcation lesions

Procedural detailsBVS & DCB group (n = 40)
Access site
 Radial32 (80%)
 Femoral8 (20%)
 LM diseased1 (2.5%)
 LAD diseased23 (57.5%)
 LCX diseased11 (27.5%)
 RCA diseased8 (20%)
 Syntax score15.04 ± 7.18
Medina class
 1,1,127(67.5%)
 1,1,00(0%)
 1,0,10%
 0,1,19 (22.5%)
 0,1,01 (2.5%)
 1,0,01 (2.5%)
 0,1,12 (5%)
 OCT3 (7.5%)
 IVUS10 (25%)
ACC/AHA
 A0%
 B12 (5%)
 B234 (85%)
 C4 (10%)
 Denovo lesions100%
 ISR0%
 Thrombus5 (2.5%)
 CTO6 (15%)
 RVD (proximal MV) (mm)3.13 ± 0.4
 Lesion length (MV) (mm)21.42 ± 16.25
 RVD SB (mm)2.31 ± 0.34
 MLD MV (mm)0.51 ± 0.37
 MLD SB (mm)0.77 ± 0.62
 Lesion length (SB) (mm)11.49 ± 6.35
 % stenosis MV83.2 ± 13.4%
 % stenosis SB66.79 ± 24%
 Predilatation MV40 (100%)
 Predilatation MV balloon diameter2.81 ± 0.45 m
 Predilatation pressure (atm)13 ± 0.36
 Scoring balloon MV1 (2.5%)
 Rotablator MV0%
 Type of BVSAbsorb (100%)
 Length BVS (mm)22.02 ± 6.07
 Second BVS used7 (17.5%)
 Inflation pressure BVS (atm)10.92 ± 1.4 atm
 Post dilatation of BVS40 (100%)
 Post dilatation balloon diameter (mm)3.31 ± 0.39
 Inflation pressure of postdilatation balloon (atm)20.3 ± 4.4
Predilatation SB32 (80%)
KB before stent implantation5 (12.5%)
Kissing balloon inflation23(57.5%)
Predilatation of SB balloon diameter2.25 ± 0.33
Predilatation SB balloon inflation pressure11 ± 3 atm
Type of DCB used
 Pantera Lux6 (15%)
 Elutax SV11 (27.5%)
 Restore6 (15%)
 Sequent please4 (10%)
 In.Pact Falcon10 (25%)
 Danubu1 (2.5%)
 Agent1(2.5%)
 Magic1 (2.5%)
 Diameter of DCB2.43 ± 0.37 mm
 DCB length20.36 ± 6.42 mm
 DCB inflation pressure9.4 ± 1.9 atm
 DCB inflation duration52 ± 10 sec
 FKB with normal balloons6 (15%)
 FKB with DCB17 (42.5%)
 Dissection left after DCB6 (15%)
Type of dissections
 A5 (12.5%)
 C1 (2.5%)
Stenting of SB0%
Final % diameter stenosis MB5.3 ± 8%
Final % diameter stenosis SB13.0 ± 16.4%
Final MLD MB (mm)3.0 ± 0.43 mm
Final MLD SB (mm)1.9 ± 0.5 mm
Total amount of contrast (ml)212 ± 117
Procedural time (min)71.8 ± 38 min
Total fluoroscopy time (min)12 ± 3.9 min
BVS/DES-related complications0%
BVS underexpansion0%
Longitudinal deformation0%
BVS recoil0%
Final TIMI less than 30%
Intraprocedural occlusiom0%
Intraprocedural death0%
Peri-procedural MI0%
Medications at discharge
 Aspirin40(100%)
 Clopidogrel11(27.5%)
 Prasugrel4 (10%)
 Ticagrelor25(62.5%)